Drug Index



Mechanism :

Dronabinol is a cannabinoid which has complex effects on the central nervous system (CNS), including central sympathomimetic activity. Cannabinoid receptors have been discovered in neural tissues. These receptors may play a role in mediating the effects of dronabinol and other cannabinoids.

Indication :

• Nausea and vomiting associated with cancer chemotherapy

Contraindications :

Dronabinol should not be given to patients sensitive to marijuana, other cannabinoids or sesame oil. Dronabinol should not be given to patients with a history of psychotic disorders or those judged to be intolerant of the drug.

Dosing :

Initial Dose: 5 mg/sqm dose given 1 to 3 hours prior to administration of chemotherapy.

Repeat Dose: 5 mg/sqm dose every 2 to 4 hours following chemotherapy, when necessary, and may be increased gradually upto 15 mg/sqm for a total of not more than 4 to 6 doses/day usually for 1 or 2 days.

Adverse Effect :

Dizziness, drowsiness, transient impairment of sensory and perceptual functions, muscular pains, asthenia, syncope, psychotropic effects, tinnitus, nightmares, facial flushing, speech difficulty, perspiration, diarrhea, faecal incontinence.

Interaction :

Avoid doxylamine, sodium oxybate.

03/06/2020 15:13:01 Dronabinol
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0